The Story of a Hero – Adam Milstein

It is not an exhaustive list of philanthropists if Adam Milstein is not in it. He was born in 1952, in Haifa, Israel. Adam is an Israeli – American whose life and career is worth talking about. He wears many hats. Besides being an active philanthropist, via various platforms, Adam is a well-known real estate investor, and a managing partner at Hager Pacific Properties.

Hager Pacific specializes in the acquisition, rehabilitation and re-positioning of the retail, office, multi-family, and industrial property. His role at the company includes overseeing the financing, accounting, and disposition operations. Adam is also the national chairman of the Israeli-American Council. He never misses an opportunity to extend his generosity. For instance, he serves as the president of Adam & Gila Milstein Family Foundation which she co-founded with his wife, Gila Milstein.

Adam Milstein has consistently been in the spotlight for his passion for changing the world. In October 2016, for instance, he appeared on the list of top 50 influential Jewish figures by Jerusalem Post. These are individuals who have brought positive change in the world over the last years and have the capacity to bring more change in the years ahead.

He was number 39 on the list, due to his outstanding leadership skills in the Israeli-American Council. His works as philanthropists, an activist and a leader in numerous other prominent Jewish organizations were also considered. Other people on the list include Benjamin Netanyahu, the Israeli prime minister, Charles Schumer, a US senator and Ruth Bader Ginsburg, a Supreme Court judge. These are personalities known for their exemplary performance in their various roles and works.

The significant role he plays in the real estate industry cannot go unnoticed. It is worth noting that Adam is a top real estate entrepreneur in both Jerusalem and Israeli areas. He offers personalized consultative services to help people find real estate opportunities capable of promoting the growth of their companies and families. Many individuals have benefited from his resourcefulness.

It is said that no one has ever become poor because of giving. Adam believes in sharing his finances and advice to leave this world better than he found it. It explains why Adam has grown to become a top real estate entrepreneur over the years. Reports by the Jewish Journal reveals that Milstein is making significant strides towards building his empire that will make him one of the best real estate investors in Israel.

NextBank Broadens Its Business Portfolio

If you’re unfamiliar with NextBank Capital, it is a leading financial services company, founded in 1922 and headquartered in Dallas, TX. NextBank is comprised of three operating platforms, which includes commercial banking, mortgage banking, and investment banking. As of June 2016, NexBank Capital, Inc. accumulated $38.1 million in net income, and an impressive 37.6% return on average equity. Combined, Nextbank boasts assets that exceed $3.5 billion. In addition, NextBank has also seen an increase in deposits; according to an article in PR News Wire, NextBank’s total deposits reached $2.6 billion as of June 30, 2016, denoting a 49% increase when compared to 2015 bank deposits.

According to, an unbiased major bank account comparison site, NextBank ranks as the 13th largest bank in Texas, and the 200th largest bank in the nation. In addition to providing excellent financial services to their clients, NextBank also gives back to the community. In the wake of a sniper attack in downtown Dallas, NextBank donated funds to the “Assist the Officer Foundation,” a non-profit organization that provides short-term assistance to the families of fallen and wounded, Dallas police officers.

In an effort to further broaden its business portfolio, NextBank SSB, a division of NexBank Capital, recently acquired the New Jersey-based, College Savings Bank of Princeton. Although the terms were not disclosed, the acquisition will create new business opportunities for the Dallas based bank, most notably in college-savings programs; according to, NextBank will gain access to 529 college saving programs previously handled by College Savings Bank of Princeton.

Why would NextBank acquire College Savings Bank of Princeton? It’s actually quite simple, NextBank is a financial institution predicated on providing diversified financial services, and the acquisition aligns with their vision of providing a one-stop-shop for their clients. NextBank is setting a new standard in the financial services industry by listening to their clients, and periodically reshaping their business model to meet their needs.



Settle Genetics is situated at Cascade Business Park. Founded in 1998, the company study’s manipulates and packages drugs for the bio tech industry. The company hopes to graduate from a biotech company to a company to reckon with in the pharmaceutical industry. To achieve this, it has invested heavily in research and marketing.

The company market value is at $10 billion, and it has 900 employees, and it is one of the largest biotech companies in Washington. Under the leadership of Clay Siegall the company’s president, chairman, CEO and co-founder, the company has a list of drugs on its pipeline that it hopes will become a great success.

The company ambition to become a global pharmaceutical firm can also be seen in the desire of the enterprise to not only develop drugs but also to handle international marketing complexities of the drugs. Through its partnership with Takeda Oncology, the firm has learned about the global markets, and it has opened a new office in Switzerland that allows it to do international marketing of its drugs.

In February this year, the company’s bid of $2billion to gain worldwide rights for commercialization of a cancer drug developed by Immunomedics showed another sign that Settle Genetics was committed to reaching the global market. Although the firm withdrew the offer after it was ruled the deal could not close due to a struggle to control the board of Immuno medics, the move showed that Siegall was committed to acquire new drugs rights and market them to international markets.


Although the company has not made any profits yet, its sales have risen over the years, and its share price has tripled from $20 to $60 in the past five years. Settle Genetics focus is on antibody-drug conjugate or ADC and four of such drugs that have potential include adcetris which has been approved by FDA. Adcetris is used as the second or third line drug for Hodgkin lymphoma. A clinical study done to compare the drug with standard therapy for newly diagnosed patients could see the drug become the first therapy if results from the study expected in the year are favorable.

The 33A is another drug that targets acute myeloid leukemia. The third drug is 22ME whose target is bladder cancer, and the fourth is LIC1 for breast cancer. Siegall’s aim is to focus on the goal and though he admits that making drugs has never been an easy task he hopes the company can continue on its progress of making drugs against cancer.

This Man Clay Siegall

Clay Siegall serves as the CEO, Chairman, and president of Seattle Genetics. Through his leadership, the firm has built several cancer therapies which include ADCETRICS which was approved by FDA in 2011.Through his guidance, Seattle Genetics has secured more than $330 million capital from public and private companies.

The company has also entered into various partnerships including with Genetech, Curagen, Bayer, and Progenics that has seen more than $65million of sales generated from 2001. He has over 20 years’ experience in development of therapeutic drugs and cancer research. He admires and has used some of Aet Levinson moves with biotech Genetech to structure Settle Genetics, and his decision to diversify his financing to more than one drug research has seen the company continue to grow.


Matthew Autterson’s Commitment to CNS Bioscience is Unwavering

Before Matthew Autterson began working on the board at CNS Bioscience, he was doing things in finances that made it hard for him to actually help people. He has always wanted to make sure that things would get better and that he could try different things so he knew what he needed to do to make CNS Bioscience better when he first started there. All of this was something that he was dedicated to and something that he knew a lot about because of the issues that were going on in the industry and because of all of the things that he had studied about it before he made the choice to join the company and help other people out with their issues.

As Matthew Autterson continued to work for the company, he did what he could to help people and show them what they were missing out on. He wanted the people who were working for the company as clinicians to be able to have free reign over the trials. He also wanted the people who were patients in the trials to have a chance at a positive experience no matter what was going on with their own health during this time.

Clinical trials can be complicated and it is something that companies must be very careful with. While Matthew Autterson has been working on the board for long enough to know what he needs to do, CNS Bioscience still has to make sure that they are doing things the right way and that people are going to be able to continue enjoying the opportunities that they have with the company. Making even a small mistake will be enough to bring a company down and can even be fatal with the results that are a part of the business.

For Matthew Autterson to try different things, he has to go through different things. He wants to make sure that he is doing things right, though, and always checks with federal resources to make sure that he can try different things. He has a lot of experience with the things that he is doing and has spent a lot of time learning about CNS Bioscience. The approach that he took made it easy for him to try new things and to do more than what he had already offered people. While Matthew Autterson was doing all of this, he was also preparing the company for success.


Anthony Petrello is Among the Highest Paid CEOs

Although Anthony Petrello is unknown in most American households, he is regarded as one of the most important and best-paid people in America. It is true that Anthony Petrello is not on the screens of the television like most politicians, but he is among the people who have helped craft the American life.

In 2014, he was ranked among the highest paid Americans. Case in point, his salary in 2014 totaled to $68.2 million as he worked with Nabors Industry. His 2014 salary was a 246% increase from what he had earned in 2012. His salary in 2012 had earned him a place in AP and Equilars lists of the highest paid CEOs in the America. He would have been unable to retain this title in 2014 owing to the reactions of angry shareholders who may have felt depleted, but Anthony did it anyway.

Although most people would envy Petrello’s high hearings, they are earned genuinely. He deserves every coin he earns as he is very hardworking and pivotal in the American economy. Tony is the Chief Executive Officer and President of Nabor Industries. Nabors is a leading natural gas and oil drilling Organization. The Company is not a producer of oil but is an oil field service driller and contract driller that have had voracious acquisitions over the years. It has over 500 rigs, which are in active use in 25 countries.

Nabor got into the Nabors Board of Directors in 1991. Before that, he worked in the Baker and Mackenzie Law Firm, where he was corporate tax specialist. In 2002, Nabors chairman Eugene Isenberg managed to take the company offshore in 2002 as he incorporated it in Hamilton, which is in Bermuda. The above was done as an attempt to cut the company’s federal tax bills while still leaving the main offices in Houston. Most shareholders felt that the Bermuda company laws would rob them of their rights, causing most of them to sue the company for reversal of the move. Nevertheless, their attempts failed, and Nabor later moved to Ireland. However, these controversial moves made Inserberg be replaced by Anthony Petrello in 2011 as the CEO. Petrello also became chairman of the company board in 2012.


Wal-Mart Carries Beneful Dog Food

Wal-Mart stores carry several Beneful varieties for shoppers looking for the dog food brand for their pet. They carry the Healthy Weight line of Beneful, as well as the Originals, to name a few. Buying Beneful at Wal-Mart is easy, and it ensures that you get the best price for the product. Shop for Beneful in-store or online at Wal-Mart. Free two-day home delivery is offered to online shoppers.

Wal-Mart provides an array of Beneful dog food options so finding exactly what you want is simple. They offer small, medium, and large bags of dog food, as well as wet food in many varieties. Buying in bulk packages is also an option. Use coupons when shopping for your Beneful dog food at Wal-Mart for the absolute lowest possible prices for the product.